Nab-paclitaxel plus carboplatin as an effective and safe chemotherapy regimen for pulmonary carcinosarcoma with interstitial lung disease: A case report

Carcinosarcoma is a rare histological type of non-small cell carcinoma (NSCLC), and its prognosis has been reported to be worse compared with other NSCLCs. Nanoparticle albumin-bound paclitaxel (nab-PTX) + carboplatin (CBDCA) achieves a favorable response rate in patients with non-small cell lung ca...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Respir Med Case Rep
Autori principali: Niwa, Hideyuki, Otani, Sakiko, Nakada, Norihiro, Sasaki, Jiichiro, Saka, Hideo, Masuda, Noriyuki
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2018
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5925955/
https://ncbi.nlm.nih.gov/pubmed/29719799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2018.01.006
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi